Comparison of Enterococcus faecium Bacteremic Isolates from Hematologic and Non-hematologic Patients: Differences in Antimicrobial Resistance and Molecular Characteristics

키워드

참고문헌 (30)

1. Wisplinghoff H, "Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study", Clin Infect Dis, 39, pp.309~317 (2004)[DOI]
2. Cho SY, "Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study", BMC Infect Dis, 13, pp.504~ (2013)[DOI]
3. 권재철, "Epidemiology and Clinical Features of Bloodstream Infections in Hematology Wards: One Year Experience at the Catholic Blood and Marrow Transplantation Center", Infection and Chemotherapy, 45(1), pp.51~61 (2013), 대한감염학회[DOI]
4. Vergis EN, "Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study", Ann Intern Med, 135, pp.484~492 (2001)[DOI]
5. Peel T, "Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia", Clin Microbiol Infect, 18, pp.388~394 (2012)[DOI]
6. Bonten MJ, "Vancomycin-resistant enterococci: why are they here, and where do they come from?", Lancet Infect Dis, 1, pp.314~325 (2001)[DOI]
7. Rosvoll TC, "PCR-based plasmid typing in Enterococcus faecium strains reveals widely distributed pRE25-, pRUM-, pIP501- and pHTbeta-related replicons associated with glycopeptide resistance and stabilizing toxin-antitoxin systems", FEMS Immunol Med Microbiol, 58, pp.254~268 (2010)[DOI]
8. Cattoir V, "Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?", J Antimicrob Chemother, 68, pp.731~742 (2013)[DOI]
9. De Angelis G, "Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis", J Antimicrob Chemother, 69, pp.1185~1192 (2014)[DOI]
10. Garner JS, "CDC definitions for nosocomial infections", Am J Infect Control, 16, pp.128~140 (1988)[DOI]
11. CLSI, "Performance standards for antimicrobial susceptibility testing. 24th ed. CLSI supplement, M100-S24", Clinical and Laboratory Standards Institute, ~ (2014)
12. Homan WL, "Multilocus sequence typing scheme for Enterococcus faecium", J Clin Microbiol, 40, pp.1963~1971 (2002)[DOI]
13. Rosvoll TC, "Increased high-level gentamicin resistance in invasive Enterococcus faecium is associated with aac(6′)Ie-aph(2″)Ia-encoding transferable megaplasmids hosted by major hospital-adapted lineages", FEMS Immunol Med Microbiol, 66, pp.166~176 (2012)[DOI]
14. Vankerckhoven V, "Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium", J Clin Microbiol, 42, pp.4473~4479 (2004)[DOI]
15. Park SH, "Molecular epidemiology of vancomycin-resistant Enterococcus faecium bloodstream infections among patients with neutropenia over a 6-year period in South Korea", Microb Drug Resist, 17, pp.59~65 (2011)[DOI]
16. 이동건, "Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea", The Korean Journal of Internal Medicine, 26(2), pp.220~252 (2011), 대한내과학회
17. Weissinger F, "Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)", Ann Hematol, 91, pp.1161~1174 (2012)[DOI]
18. Balla E, "Characterization and cloning of the genes encoding enterocin 1071A and enterocin 1071B, two antimicrobial peptides produced by Enterococcus faecalis BFE1071", Appl Environ Microbiol, 66, pp.1298~1304 (2000)[DOI]
19. Balla E, "Molecular analysis of the gene cluster involved in the production and secretion of enterocins 1071A and 1071B and of the genes responsible for the replication and transfer of plasmid pEF1071", Int J Food Microbiol, 99, pp.33~45 (2005)[DOI]
20. Dupre I, "Incidence of virulence determinants in clinical Enteorococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy)", J Med Microbiol, 52, pp.491~498 (2003)[DOI]
21. Billstrom H, "Virulence and antimicrobial resistance in clinical Enterococcus faecium", Int J Antimicrob Agents, 32, pp.374~377 (2008)[DOI]
22. Sanchez-Diaz AM, "The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?", Clin Microbiol Infect, 22, pp.e1~e8 (2016)[DOI]
23. Laverde Gomez JA, "A multiresistance megaplasmid pLG1 bearing a hylEfm genomic island in hospital Enterococcus faecium isolates", Int J Med Microbiol, 301, pp.165~175 (2011)[DOI]
24. Yang J, "Prevalence of diverse clones of vancomycin-resistant Enterococcus faecium ST78 in a Chinese hospital", Microb Drug Resist, 22, pp.294~300 (2016)[DOI]
25. Rice LB, "Transferable capacity for gastrointestinal colonization in Enterococcus faecium in a mouse model", J Infect Dis, 199, pp.342~349 (2009)[DOI]
26. van Wamel WJ, "Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation", Infect Immune, 75, pp.924~931 (2007)[DOI]
27. Sava IG, "Pathogenesis and immunity in enterococcal infections", Clin Microbiol Infect, 16, pp.533~540 (2010)[DOI]
28. Hendrickx AP, "The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis", Future Microbiol, 8, pp.993~1010 (2013)[DOI]
29. Willems RJ, "Restricted gene flow among hospital subpopulations of Enterococcus faecium", MBio, 3, pp.e00151~12 (2012)
30. Galloway-Pena JR, "Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States", J Infect Dis, 200, pp.1566~1573 (2009)[DOI]

관련 논문AI추천